InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Hill Stephen J.. Director active across 1 company, notably Lyell Immunopharma, Inc.. Aggregated, 9 reports have been published. Split: 0 buy · 5 sells. Total volume traded: €41k. History available since 9 February 2024. The latest transaction was disclosed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Hill Stephen J. is a declarant linked to Lyell Immunopharma, Inc. The record shows 8 filings in total, and across the 8 sampled filings between 2024-02-13 and 2026-08-11, the reported activity consists of sales only, for a total of EUR 27571.